GSK completes its Canadian tripod

GlaxoSmithKline plc and the not-for-profit Centre for Drug Research and Development have partnered to fund research from academic institutions across Canada. The deal completes a trio of alliances established by the pharma in the last two years to tap promising preclinical research in Canadian academia.

CDRD was founded in 2007 and helps investigators at more than 20 institutions turn their discoveries into investment opportunities for industry by providing access to in-house resources that cover all stages of preclinical drug development, scientific and business expertise and project management skills, president and CEO Karimah Es Sabar told SciBX...